BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CSDMARDS

被引：0
|
作者：
van der Heijde, D. [1 ]
Dougados, M. [2 ]
Chen, Y. -C. [3 ]
Greenwald, M. [4 ]
Drescher, E. [5 ]
Klar, R. [6 ]
Xie, L. [7 ]
de la Torre, I. [7 ]
Rooney, T. P. [7 ]
Witt, S. [7 ]
Schlichting, D. [7 ]
DeBono, S. [7 ]
Emery, P. [8 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Cochin Hosp, Paris, France
[3] Chang Gung Mem Hosp Kaohsiung, Kaohsiung, Taiwan
[4] Desert Med Adv, Palm Desert, CA USA
[5] Veszprem Csolnoky Ferenc Cty Hosp, Veszprem, Hungary
[6] Quintiles Transnat INC, Durham, NC USA
[7] Eli Lilly & Co, Indianapolis, IN 46285 USA
[8] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1611
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0168
引用
收藏
页码：244 / 245
页数：2
相关论文
共 50 条
  • [31] Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
    Désirée van der Heijde
    Patrick Durez
    Georg Schett
    Esperanza Naredo
    Mikkel Østergaard
    Gabriella Meszaros
    Francesco De Leonardis
    Inmaculada de la Torre
    Pedro López-Romero
    Douglas Schlichting
    Eric Nantz
    Roy Fleischmann
    Clinical Rheumatology, 2018, 37 : 2381 - 2390
  • [32] Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
    van der Heijde, Desiree
    Durez, Patrick
    Schett, Georg
    Naredo, Esperanza
    Ostergaard, Mikkel
    Meszaros, Gabriella
    De Leonardis, Francesco
    de la Torre, Inmaculada
    Lopez-Romero, Pedro
    Schlichting, Douglas
    Nantz, Eric
    Fleischmann, Roy
    CLINICAL RHEUMATOLOGY, 2018, 37 (09) : 2381 - 2390
  • [33] Visualisation of structural damage as a surrogate marker of radiographic progression in patients with rheumatoid arthritis
    Pfeil, Alexander
    Oelzner, Peter
    Renz, Diane M.
    Lehmann, Gabriele
    Wolf, Gunter
    Boettcher, Joachim
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) : E24 - E24
  • [34] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CSDMARDS: SUMMARY RESULTS FROM THE 24-WEEK PHASE III RA-BUILD STUDY
    Emery, Paul
    Krogulec, Marek
    Blanco Alonso, Ricardo
    Rossini, Maurizio
    Raeman, Frank
    Walker, David
    Ghizdavescu, Andrei Petru
    Irto, Ildiko
    Luz Rentero, Maria
    Casillas, Marta
    de la Torre, Inmaculada
    Dougados, Maxime
    RHEUMATOLOGY, 2016, 55 : 60 - 60
  • [35] P134 Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with RA: results from RA-BEYOND
    van der Heijde, Desiree M. F. M.
    Kartman, Cynthia E.
    Xie, Li
    Beattie, Scott
    Schlichting, Douglas E.
    Durez, Patrick
    Tanaka, Yoshiya
    Fleischmann, Roy
    RHEUMATOLOGY, 2021, 60
  • [36] Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis (vol 5, e000898, 2019)
    van der Heijde, D.
    Schiff, M.
    Tanaka, Y.
    RMD OPEN, 2019, 5 (02):
  • [37] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE TO CSDMARDS: RESULTS FROM RA-BEYOND UP TO 7 YEARS OF TREATMENT
    Caporali, Roberto
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    RHEUMATOLOGY, 2023, 62
  • [38] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE TO CSDMARDS: RESULTS FROM RA-BEYOND UP TO 7 YEARS OF TREATMENT
    Caporali, R.
    Aletaha, D.
    Sanmarti, R.
    Takeuchi, T.
    Mo, D.
    Haladyj, E.
    Zaremba-Pechmann, L.
    Taylor, P. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 630 - 631
  • [39] Can progression of radiographic joint damage be predicted early in rheumatoid arthritis?
    Voskuyl, AE
    Boers, M
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (05) : 905 - 907
  • [40] Joint structural damage prevention with rituximab in patients with rheumatoid arthritis and an inadequate response to one or more TNF inhibitors: 1 year data from the reflex study
    Keystone, E.
    Kvien, T. K.
    Emery, P.
    Peterfy, C. D.
    Tak, P. P.
    Cohen, S.
    Genovese, M.
    Williams, S.
    Totoritis, M.
    Cravets, M.
    Shaw, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 14 - 14
12345